According to Nectar Lifesciences
's latest financial reports the company has a price-to-book ratio of 0.300038.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 0.8028 | 18.7% |
2023-12-31 | 0.6763 | 33.54% |
2022-12-31 | 0.5065 | -10.15% |
2021-12-31 | 0.5637 | 15.66% |
2020-12-31 | 0.4874 | 101.76% |
2019-12-31 | 0.2416 |